Association between visual hallucinations and α-synuclein oligomers in patients with dementia with Lewy bodies

路易体痴呆患者的视觉幻觉与α-突触核蛋白寡聚体之间的关联

阅读:2

Abstract

INTRODUCTION: Visual hallucinations (VHs) represent one of the core clinical features of dementia with Lewy bodies (DLB); however, their underlying pathology remains unclear. METHODS: We employed proximity ligation assay (PLA) and phosphorylated α-synuclein (αSYN) immunohistochemistry to compare αSYN oligomers and Lewy-related pathology across brain regions along the ventral visual pathway in patients with and without VHs (five patients each). RESULTS: Greater αSYN oligomer burden in the parahippocampal cortex was observed in patients with VHs compared to those without (p = 0.041), whereas the burden of Lewy-related pathology was similar between groups. DISCUSSION: Our findings suggest that αSYN oligomers, rather than conventional Lewy-related pathology, may be more closely associated with VHs in DLB. This provides novel evidence linking αSYN oligomers to a core clinical feature in DLB and suggests potential therapeutic targets for managing VH in these patients. HIGHLIGHTS: Visualization of αSYN oligomers by PLA and quantitative neuropathologic analysis. Abundant αSYN oligomers in parahippocampal cortex of DLB with VHs. First human brain study linking αSYN oligomers to VHs. Potential oligomer-targeted therapy for managing VH in DLB.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。